Author

Suelen Cristina Soares Baal

Universidade Federal do ParanáORCID 0000-0002-7172-0406Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:long-read sequencing· 1

Frequent Co-Authors

António JacintoiD· 1 shared Bruna CorreiaiD· 1 shared Carlos Mendez‐DorantesiD· 1 shared Carolina MathiasiD· 1 shared Cátia Rebelo de AlmeidaiD· 1 shared D.S.C.P. Grosa· 1 shared Daniela Moreira MombachiD· 1 shared Diana P. SaraivaiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

António JacintoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 16, 2026

Transposable elements shape olaparib response according to BRCA1 status in triple-negative breast cancer

Daniela Moreira Mombach, Carlos Mendez‐Dorantes, Rafael L. V. Mercuri…·Pedro A. F. Galante

This paper shows that olaparib treatment increases transposable element activity in BRCA1-deficient triple-negative breast cancer cells, leading to genomic instability and immune responses.

DOI 10.64898/2026.07.15.738694

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologyFrontiers in ImmunologyPeer-reviewedSep 19, 2025

Enhancing HLA-DR in Cytotoxic T Lymphocytes is crucial for the development of efficient adoptive T cell Therapies for Breast Cancer

Rute M. Salvador, Bruna Correia, D.S.C.P. Grosa…·Maria Guadalupe Cabral

This study shows that enhancing HLA-DR expression in cytotoxic T lymphocytes improves their anti-tumor activity, suggesting strategies to optimize adoptive T cell therapies for breast cancer.

5 citations

humanscRNA-seq

𝕏 PostBluesky